Drugs / Seasonal influenza vaccine
Trials 15
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 11 trial | ||||||
| Phase 1 | NCT02988739 | Feb → Jul 2017 | influenza | Pantec Biosolutions AG | Completed | No outcome recorded |
| Phase 24 trials | ||||||
| Phase 2 | NCT01357265 | May 2011 | influenza | Novartis Vaccines | Completed | No outcome recorded |
| Phase 2 | NCT01344057 | May → Jun 2011 | influenza | Novartis Vaccines | Completed | No outcome recorded |
| Phase 2 | NCT00956449 | Jun → Jul 2009 | influenza | Novartis | Completed | No outcome recorded |
| Phase 2 | NCT00734734 | Jun → Jul 2008 | — | Novartis Vaccines | Completed | No outcome recorded |
| Phase 35 trials | ||||||
| Phase 3 | NCT05028634 | Nov 2021 → Nov 2023 | relapsing-remitting multiple sclerosis | Celgene Corporation | Completed | No outcome recorded |
| Phase 3 | NCT01687517 | Oct 2012 → Jun 2013 | sarcoidosis | Assistance Publique - Hôpitaux de Paris | Completed | No outcome recorded |
| Phase 3 | NCT01422512 | Sep → Oct 2011 | influenza | Novartis Vaccines | Completed | No outcome recorded |
| Phase 3 | NCT01063088 | Feb → Mar 2010 | influenza | Alachua Government Services, Inc. | Completed | No outcome recorded |
| Phase 3 | NCT00735410 | Jun → Jul 2008 | — | Novartis Vaccines | Completed | No outcome recorded |
| Phase 43 trials · 1 met primary | ||||||
| Phase 4 | NCT05108818 | Oct 2021 → Apr 2027 expected | influenza | University of Pennsylvania | Recruiting | No outcome recorded |
| Phase 4 | NCT02748785 | Sep 2015 → Aug 2016 | rheumatoid arthritis | Seoul National University Hospital | Completed | Met primary |
| Phase 4 | NCT02105519 | Oct 2013 → Jun 2014 | chronic kidney disease | National Cheng-Kung University Hospital | Unknown | No outcome recorded |
| Phase not applicable2 trials | ||||||
| — | NCT01906190 | Aug 2011 → Mar 2013 | influenza | Centers for Disease Control and Prevention, China | Completed | No outcome recorded |
| — | NCT01202552 | Oct 2010 → Apr 2018 | influenza | Queen Saovabha Memorial Institute | Completed | No outcome recorded |
| Comparator or background therapy9 trials | ||||||
| Phase 1 | NCT01444482 Comparator | May → Nov 2011 | influenza | Isconova AB | Unknown | No outcome recorded |
| Phase 1 | NCT01405885 Comparator | May 2011 → Aug 2013 | — | Inovio Pharmaceuticals | Completed | No outcome recorded |
| Phase 1 | NCT00798343 Comparator | Jan 2009 → Mar 2010 | influenza | University Hospitals, Leicester | Completed | No outcome recorded |
| Phase 2 | NCT03300362 Background | Oct 2017 → Oct 2018 | influenza | Barinthus Biotherapeutics | Terminated | No outcome recorded |
| Phase 2 | NCT00620815 Comparator | Nov 2007 → Jan 2008 | influenza | Novartis Vaccines | Completed | Met primary |
| Phase 3 | NCT01199861 Background | Aug 2010 → May 2011 | multiple sclerosis | Novartis | Completed | No outcome recorded |
| Phase 3 | NCT01040078 Comparator | Dec 2009 → Feb 2010 | swine influenza | Centers for Disease Control and Prevention, China | Unknown | No outcome recorded |
| Phase 4 | NCT01980836 Comparator | Nov 2013 → Feb 2014 | rheumatoid arthritis | Tel-Aviv Sourasky Medical Center | Unknown | No outcome recorded |
| — | NCT02765126 Comparator | May 2016 → Dec 2019 | — | Clifford Craig Medical Research Trust | Unknown | No outcome recorded |
Press releases naming this drug 5 releases
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 24 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | seasonal influenza vaccine | “Non-adjuvanted seasonal influenza vaccine (total dose 45ug)” NCT00798343 ↗ |
| Known as | FLUAD | “A Phase II, Open Label, Uncontrolled, Multi Center Study to Evaluate Safety and Immunogenicity of FLUAD® Surface Antigen, Inactivated, Adjuvanted With MF59C.1 Influenza...” NCT00734734 ↗ |
| Modality | Vaccine | “seasonal influenza vaccine” NCT00620815 ↗ |
| Route | Intramuscular | “1 single intramuscular dose of influenza vaccine, 2008/2009 NH formulation” NCT00734734 ↗ |